Le Lézard
Classified in: Science and technology, Business
Subjects: PER, CXP

Hyperscience Achieves Record Growth in 2019, Driven by Accelerating Demand for Intelligent Document Processing


NEW YORK, Jan. 30, 2020 /PRNewswire/ -- Hyperscience, the developer of next-generation intelligent document processing solutions for the enterprise, today announced that it has achieved key corporate milestones in 2019, including raising $30M in Series B funding, tripling its customer base, expanding its partner ecosystem, and doubling its team. The company is also on track to achieve its international expansion goals with the opening of its second European office in London.

HyperScience is the automation company making data flow within and between the world's leading financial services, insurance, healthcare and government organizations, including TD Ameritrade and QBE. For more information please visit www.hyperscience.com. (PRNewsfoto/HyperScience)

Hyperscience's accelerated growth is being driven by the increasing need for foundational automation solutions that can handle diverse document and data types, as well as eliminate manual processes and free up employee capacity to focus on customer needs.

"We are seeing great success because we solve one of the most pressing problems an enterprise has today," said Charlie Newark-French, Chief Operating Officer, Hyperscience. "Enterprises run on data collected through a myriad of sources and formats, which enables them to extract key insights to unlock efficiencies and stay competitive. Unfortunately, companies are spending over $60 billion each year in order to convert documents into formats that can be read by various systems. Our intelligent document processing solution automates this process and also lays the groundwork for greater downstream AI, analytics and strategic digitization initiatives."

Leading Enterprises, Partners and Analysts Recognize Hyperscience
Over the last twelve months, the company tripled its customer base within key verticals, including financial services and insurance. Hyperscience customers experience as much as a 67% decrease in error rates and a 10-fold increase in processing capacity.

Since June 2019, Hyperscience has expanded its partnership base to include leading Robotic Process Automation (RPA) providers UiPath and Blue Prism, as well as top strategic advisory and Systems Integrator (SI) firms. Hyperscience complements these companies' initiatives, helping customers to unlock and access data from unstructured document types (e.g. PDFs, images, and more) and to promote continuous improvement initiatives.

In March, Hyperscience was also recognized as a "Major Contender" in the 2019 Everest Group Intelligent Document Processing (IDP) Products PEAK Matrixtm report.

Leadership Team Expansion, New Hires Support Long-Term Growth
To keep pace with growing demand, Hyperscience added more than 85 new employees across all functions, including R&D, sales, marketing and operations. The company, which was named one of Built In NYC's Best Places to WorkBest Midsize Companies to Work For, Best Paying Companies and Companies With the Best Benefits in 2020, will continue to focus on strategic hiring this year.

Last year, Hyperscience expanded its leadership team to include executives with extensive enterprise technology, SaaS and domain expertise, including Manya Ellenberg as Vice President, People; Charlie Newark-French as Chief Operating Officer; Jon-Marc Patton as Vice President, Customer Success; Nelly Rinot as Vice President, Marketing; Bill Strogis as Vice President, Worldwide Sales; and Luke Surazski as Vice President, Engineering.

"I am especially proud of our ability to attract experienced and accomplished individuals who  feel at home at Hyperscience," remarked Peter Brodsky, CEO and co-founder, Hyperscience. "In the past year, we have added individuals who will help lead the company's next phase of growth and product leadership. This is one of our most significant achievements and it will continue to have an impact on our mission, growth and people."

HyperGrowth in 2020
Hyperscience is continuing to cement its market leader position in 2020, including expanding its customer base in North America and EMEA and building out its team. The company also plans to announce the next evolution of the Hyperscience platform in the second half of the year, including new capabilities and improvements to its Intelligent Document Processing solution.

About Hyperscience
Hyperscience is the automation company that enables data to flow within and between the world's leading firms in financial services, insurance, healthcare and government markets, including TD Ameritrade, QBE and Voya Financial, among others. Founded in 2014 and headquartered in New York City with offices in Sofia, Bulgaria and London, UK, Hyperscience has raised over $50M in venture funding from leading VCs, including Stripes Group and FirstMark Capital. For more information please visit www.hyperscience.com.

Follow Hyperscience on Twitter and LinkedIn.

Media Contacts
Pardes Communications, LLC
Diane Pardes
dpardes[at]pardescommunications.com
978-254-7948

Linda Pendergast-Savage
pendergast[at]pardescommunications.com
508-224-7905

SOURCE Hyperscience


These press releases may also interest you

at 14:30
Transaction in Own Shares 28 March, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 28 March 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according...

at 14:30
Southwest Airlines Co.  announces the acquisition of SAFFiRE Renewables, LLC (SAFFiRE) as part of the investment portfolio of its wholly owned subsidiary Southwest Airlines Renewable Ventures, LLC (SARV). SARV is dedicated to creating more...

at 14:28
Nuventive, the data-informed improvement companytm, today announced a partnership with D2L, a global learning technology company, to simplify student outcomes analysis and advancement. By linking reports from the D2L Brightspace learning management...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 14:20
Koryx Copper Inc. ("Koryx" or the "Company") announces that the Company has closed a non-brokered private placement (the "Offering") for a total gross proceed of $1,505,250. The Offering closed 23,157,692 units of the Company (each, a "Unit") at...

at 14:20
Mishe (say "mish-e"), an innovator in direct healthcare, announces the launch of Downstate's Transparent Access Plan, making SUNY Downstate Health Sciences University the first hospital system in the US to offer transparent upfront pricing for its...



News published on and distributed by: